eHAND Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of eHAND monoclonal antibodies for advanced research in developmental biology and cardiology. eHAND monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). eHAND, a member of the Hand transcription factor family, plays a crucial role in cardiac development and differentiation. eHAND is essential for heart formation and regulates gene expression during embryogenesis. Understanding eHAND function provides critical insights into mechanisms underlying congenital heart defects and other cardiovascular diseases. Researchers can explore molecular pathways governing heart development using advanced detection methods. eHAND expression patterns can be precisely mapped across different developmental stages and tissue types. Investigating eHAND interactions with other transcription factors helps reveal complex regulatory networks in cardiac development. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cardiovascular development and disease mechanisms.